Company news
Aethlon Medical, Inc. news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Aethlon Medical Announces First Patient Treated in First-in-Human Clinical Trial of HEMOPURIFIER® in Head and Neck Cancer
December 15, 2020
Aethlon Announces Appointment of Charles J. Fisher, Jr., M.D. as Chief Executive Officer
November 2, 2020
Aethlon Medical To Release Second Quarter Financial Results and Host Conference Call on October 28, 2020
October 18, 2020
Aethlon Medical Announces Collaboration with University of Pittsburgh on NIH Grant for Head and Neck Cancer
August 5, 2020
Aethlon Medical To Release First Quarter Financial Results and Host Conference Call on August 11, 2020
August 3, 2020
Aethlon Medical Announces Fiscal Year Financial Results and Provides Corporate Update
June 24, 2020
Aethlon Announces FDA Approval of IDE Supplement for COVID-19 Patients
June 17, 2020
Aethlon Medical To Release Fourth Quarter Financial Results and Host Conference Call on June 25, 2020
June 15, 2020
Aethlon Announces Issuance of European Patent for the Hemopurifier® in Cancer
March 23, 2020
Aethlon Medical Announces Completion of $3.77 Million Registered Direct Offering
January 21, 2020
Aethlon Medical Announces $3.77 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
January 16, 2020
Aethlon Medical Announces Closing of $5 Million Public Offering
December 16, 2019
Aethlon Medical Announces Pricing of $5 Million Public Offering
December 12, 2019
Aethlon Medical Announces FDA Approval Of IDE For Oncology Indications
October 6, 2019
Aethlon Announces Collaboration to Identify Exosomes Involved in Cancer Progression and Treatment Resistance
September 23, 2019
Aethlon Medical Receives National Cancer Institute Contract Award
September 15, 2019
Aethlon Medical To Release First Quarter Financial Results and Host Conference Call on August 14, 2019
August 6, 2019
Aethlon Medical, Inc. and SeaStar Medical, Inc. Announce Strategic Joint Cross-Licensing Agreement
June 30, 2019
Aethlon Medical To Release Fiscal Year End Financial Results and Host Conference Call on July 1, 2019
June 18, 2019
Aethlon Medical Announces Collaboration With Prostate On-Site Project (POP), Host Of The Jerry Colangelo Sports Legend Golf Classic, To Engage With Participants For CTE Studies
May 12, 2019
Aethlon Medical Releases Shareholder Update
April 16, 2019
Calls
The 5 newest of 17 calls. Every call is listed under its year.
- Aethlon Medical (NASDAQ:AEMD) Q1 2027 Earnings Call
Aug 13, 2026
Transcript - Aethlon Medical (NASDAQ:AEMD) Q4 2026 Earnings Call
Jun 10, 2026
Transcript - Aethlon Medical (NASDAQ:AEMD) Q3 2026 Earnings Call
Feb 12, 2026
Transcript - Aethlon Medical (NASDAQ:AEMD) Q2 2026 Earnings Call
Nov 12, 2025
Transcript - Aethlon Medical (NASDAQ:AEMD) Q1 2026 Earnings Call
Aug 13, 2025
Transcript
Decks
The 5 newest of 33 decks. Every deck is listed under its year.
- Merger or Acquisition (September 2026)
Merger or acquisition · 29 slides · Sep 17, 2026
- Investor Presentation (June 2026)
Investor deck · 21 slides · June 2026
- Investor Presentation (March 2026)
Investor deck · 21 slides · March 2026
- Investor Presentation (August 2025)
Investor deck · 21 slides · Aug 21, 2025
- Investor Presentation (February 2025)
Investor deck · 20 slides · February 2025